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Objectives: Traumatic spinal cord injury (tSCI) remains a major clinical challenge.
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Cell transplantation brings a glimmer of light, among them olfactory ensheathing cells
(OECs) have shown some neurorestorative effect. Due to the results of each group
lack basic consistency, many technical details are believed to affect the overall outcome.
We compare the clinical outcome of intramedullary transplant of olfactory ensheathing
cells for patients with spinal cord injury at multi-centers worldwide, and to explore
the potential standardized transplantation that suits for the clinical requirements.
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literatures published in the last 20 years for the clinical studies/trials of OECs for
chronic spinal cord injury in the representative clinical center. The results of these
representative clinical treatment centers were searched and analyzed. The parameters
which may affect the effect including the concentration of cells, the total number of
cells, the choice of incision, the site of transplantation, the number of transplantation
sites, the advantages and disadvantages of transplantation equipment, and postoperative
management, were compared carefully to clarify its impact on the clinical results.
Results: In these literatures, 2 Chinese centers, 1 Australian center and 1 European
center were selected for intraspinal transplantation. The reason of different results may
be due to the excessive injection times and/or the excessive total injection volume.
Conclusions: Cell implant to the spinal cord parenchyma is effective for restoring
neurological functions, but improper procedures may lead to ineffective results.
Concise surgery appears to be more suitable for clinical application than ostensibly
precise and complex injection procedures. Sufficient rehabilitation training is surely
necessary for the integration of motor recovery after cell transplantation.

1

Introduction

Traumatic spinal cord injury (tSCI), especially chronic
complete spinal cord injury can cause enormous
Corresponding author: Yuqi Zhang, E-mail: yuqi9597@sina.com

economic burden and suffering for families and
society. Currently, the neurorestoratologic strategies
have developed new therapies for patients with tSCI
from the laboratory to the clinic. Significant progress
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has been made in the field of clinical cell therapy
application for SCI, which includes neural stem cells,
oligodendrocytes, Schwann cells (SCs), olfactory
ensheathing cells (OECs), various mesenchymal stromal
cells, etc. [1, 2]. Many reports have been published
from different clinical centers worldwide in his regard.
OECs are a special type of glial cells with multiple
functional properties such as astrocytes, oligodendrocytes, and SCs. The neurorestorative potency of
the OEC has been better than other now known types
of glial cells; it can induce and guide axonal growth,
help regenerate olfactory nerve fibers across glial scars
and the barrier between peripheral and central axons,
promote the damaged nerve restoration including
axonal regeneration, myelination repair, and restore
other structural and functional impairments [3, 4].
Thus, it is generally believed that these cells have
greater application prospects [5–7]. Currently intramedullary transplantation is one of the delivery routes
for OEC therapy in SCI cases [8–16]. However, the
results of clinical studies have been reported to be
inconsistent. Because procedures for cell injection
into the spinal cord parenchyma are different, they
may result in inconsistent clinical outcomes. In this
review, a comparison is made to better promote the
standardization of cell transplantation for SCI.

2

Methods

We used the Pubmed and CNKI databases to search
online for a clinical studies and trials of olfactory
ensheathing cells (OECs) for chronic spinal cord
injury in a representative clinical center published in
the recent two decades. The language is limited to
Chinese and English (Table 1). In the end, we selected
two Chinese centers, one Australian center, and one
European center, which used intraspinal parenchymal
cell transplantation to treat chronic complete SCI.
The detailed clinical process parameters, including
the size of the spinal incision, the concentration of
transplanted cells, the total amount of transplanted
cells, the site of implantation, the total number of
transplant sites, the design and selection of transplantation devices, and postoperative clinical management
were carefully analyzed to compare their clinical
outcomes.

3

Results

The comparison between the parameters, complications,
and clinical efficacy of intra-spinal transplantation
of olfactory ensheathing cells (OECs) in the eligible
studies have been shown in Table 2. The overall results

Table 1 List of selected clinical studies on olfactory ensheathing cell transplantation for treatment of chronic complete spinal
cord injury.
Author

Nation

Year

Case (n)

Cell type

Route of transplant

Huang H, et al.

China

2003

171

OEC

cord parenchyma

Rabinovich SS, et al.

Russia

2003

15

hemopoietic tissues+OEC

subarachnoidally

Féron F, et al.

Australia

2005

3

OEC

cord parenchyma

Guest J, et al.

United States

2006

1

OEC

cord parenchyma

Lima C, et al.

Portugal

2006

7

olfactory mucosa

cord parenchyma

Huang H, et al.

China

2006

222

OEC

cord parenchyma

Mackay-Sim A, et al.

Australia

2008

6

OEC

cord parenchyma

Lima C, et al.

Portugal

2010

20

olfactory mucosal autografts

cord parenchyma

Zheng ZC, et al.

China

2010

213

OEC

cord parenchyma

Huang H, et al.

China

2012

108

OEC

cord parenchyma

Wu J, et al.

China

2012

11

OEC

cord parenchyma

Wang D, et al.

China

2012

24

OEC

cord parenchyma

Rao Y, et al.

China

2013

8

OEC

cord parenchyma

Tabakow P, et al.

Poland+UK

2013

6

autologous mucosal olfactoryensheathing cells and olfactory nerve fibroblasts

cord parenchyma
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Table 2 Comparison of surgical parameters and clinical efficacy of spinal cord parenchyma transplantation using olfactory
ensheathing cells.
Author

Case (n)

Incision
size

Transplant
site

Cell
concentration

Total
amount of
cells

Transplant
device

Huang
H,
et al. [7]

171

4 cm

The upper
and lower
boundary
areas of the
damaged
area and the
normal area,
2-4 injection
points

10,000
single
cells /µL

500,000
cells / 50 µL

4.5# syringe
needle
(approved by
the Food and
Drug Administration)

Wang D,
et al.
[11]

24

4–6 cm

Spinal gray 10,000/μL
matter at a
distance of
0.5 cm from
the distal and
proximal
ends of the
spinal cord
injury zone,
4 injection
points

500,000/
40 µL

5# syringe
needle
(approved by
the Food and
Drug Administration)

Féron F
and
MackaySim A,
et al.
[15,16]

3

4–6 cm

1µL per injections, spinal
cord injury
zone, one vertebral body
segment at the
distal end and
the proximal
end. number
of injection
points:
Case 1: 270
Case 2: 545
Case 3: 630

80,000
cells/µL

Patient 1
297μl (12
million)

Self-made
microinjection
instruments

Spinal cord
injury zone,
one vertebral
body segment
at the distal
and proximal ends,
0.5 μl per
injections,

30,000–
200,000
cells/µL

Tabakow
P, et al.
[14]

3

6–8 cm

Case 1: 20
sites (120
injections),
case 2: 40
sites (128
injections),
case 3: 46
sites (212
injections)

Average Postoperative Follow-up
operation management
time
time

Complication

Clinical efficacy

Postoperative 2–8 weeks
rehabilitation
training

No serious
complications

Improved

1.7 h (1.5 – Postoperative
3.2 yr
2.5 h)
rehabilitation (0.5−5.2 yr)
training

No serious
complications

Nine of the 10
patients had a 1 to 2
spinal cord segment
with a sensory level
of injury. There was
no change in motor
function. There was
no change in the
sensory level of injury
in 1 patient, but his
limb spasm was
significantly relieved
after surgery.

1.5 h

4h

Postoperative
rehabilitation
training

3 yr

No serious
complications

In 1# patients,
touch and pinprick
improved on both
sides of the body,
decreased more
than 3 dermatodes

9–11 h

Postoperative
rehabilitation
training

1 yr

Long-term no
complications.

The first 2 surgical
patients ASIA A to
ASIA C and ASIA B.

Patient 2
599.5μl (24
million)
Patient 1
693μl (28
million)

Case 1: 60 μL
Self-made
(1,800,000), microinjection
Case 2: 64 μL instruments
(1,920,000),
Case 3: 106 μL
(21,200,000)

Recent complications include:
fever (T1, T2, T3)

Diffusion tensor
imaging showed
Urinary tract infec- that the spinal cord
injury in these
tion (T1, T2)
patients focused on
Mild anemia (T1, T2)
the continuity of
Anemia requiring
some white matter
blood transfusion
bundles throughout
(T3)
the process.
Systemic hypoThe third surgical
tension (T3)
patient, although
Pressure sore ulcer
(T1)

maintaining ASIA A,
showed a segment of
Temporary loss of motion and sensory
musculocutaneous function below the
degree of injury.
nerve (T1)
Neurophysiological
examination showed
improvement in
spinal cord conduction and lower limb
muscle activity.
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Author

Case (n)

Incision
size

Transplant
site

Cell
concentration

Total
amount of
cells

Transplant
device

Huang
H, et al.
[10]

108 (79
cases in
rehabilitation
group;
29 cases
in poor
rehabilitation
training)

2–3 cm
keyhole
surgery

The upper
and lower
boundary
areas of the
damaged
area and the
normal area,
2–4 injection
points

10,000
single
cells /µL

500,000
cells / 50μL

4.5# syringe
needle
(approved by
the Food and
Drug Administration)

revealed different degrees of improvement in neurological status such as sensory and motor function
after the treatment. Early results were confirmed by
long-term follow-up. The results further show that
multiple injections with large volume of the cell solution may lead to iatrogenic spinal cord injury and
ineffectiveness of the treatment. This situation may
be observed in the two patients of the Australian
team who injected 300 μL (545 injection points into the
spinal cord in one case, and 24 million cells), 350 μL
(630 injection points, 28 million cells) in the second
case.

Average Postoperative Follow-up
operation management
time
time
1h

4

Postoperative
rehabilitation
training

3.47 ±
1.12 yr

Complication

Clinical efficacy

None

The average ASIA
motor score of 108
cases increased from
37.79±18.45 to
41.25±18.18, the light
touch score was from
50.32±24.71 to 55.90±
24.46, the pinprick
score was from 50.53±
24.92 to 54.53±24.62;
the IANR-SCIFRS
score increased
from 19.32±9.98 to
23.12±10.30. Sufficient rehabilitation
training has a significant impact on the
improvement of
motor scores. 14 cases
(12.96%) improved
ASIA A to ASIA B; 18
cases (16.67%)
improved ASIA A to
ASIA C, 9 of which
(8.33%) improved
walking ability or they
used walking device
with or without help
Walking; 12 of 14.
males (14.29%)
improved sexual
function. Electromyography was
performed on 31
patients; 29 patients
showed improvement and the other 2
did not change significantly. PVSEP test:
of the 31 patients,
28 showed improvement and the
remaining 3 did
not change.

Discussions

The biological properties of olfactory ensheathing cells
(OECs) make them suitable for promoting neurorestoration including axonal regeneration, neuroplasticity, myelination repair, stimulating angiogenesis,
changing local microenvironment through releasing
cytokines or secreting neurotropic or growth factors
and more other neurorestrorative mechanisms in the
injured spinal cord. OECs can interact with glial scars
and improve functional outcomes with rehabilitation
for SCI [10, 17, 18]. Although intrathecal injection is
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a less invasive option, most researchers still believe
that OECs can be directly transplanted into the adjacent
segment of spinal cord by injecting micro-uploaded
cell suspensions using fine needles or glass capillaries.
Actually intramedullary injection seems to be the best
route for cell transplantation [8]. After intramedullary
injection the transplanted cells can interact directly
with the host environment.
However, it is worth noting that the intramedullary
injection of the OECs may be associated with the
following risks: damaging spinal cord by needle
injection, possible spinal cord ischemia due to high
pressure gradient and hydrodynamic separation in the
spinal cord parenchyma with large injection volumes
[19]. Therefore, the location of cell transplantation, the
concentration of cells, the total amount of cells, injection
devices, and transplantation surgical techniques are
very important for safety and efficacy.
In theory, more tiny microinjections may promote
the integration of transplanted cells with the host
tissue, which has certain benefits. In experimental
animals, very fine multi-point small volume injections
could be performed for long periods of time. However,
the human spinal cord is completely different from
experimental animals (including primates). Human
spinal cord movement or floating range is larger,
associated with breathing, and heartbeat. From a
clinical perspective, clinical practical needs are the first
choice and consideration rather than animal experiments. In order to reduce needle damage, fewer handheld injections may be the best choice at present time
(the failure of patients 2# and 3# in Australian studies
provides evidence). Especially in the cervical spine
and T11-L1 segments, any secondary damage to the
incompletely injured spinal cord and the patient’s
existing neurological function is unacceptable and
should be avoided.
Regarding the choice of incision size, the spinal
cord segment that needs to be transplanted should
generally be exposed, but the keyhole surgery used by
Dr. Huang’s team appears to be an option for patients
without adhesion and cystic abnormality, with an
average operation time about 1 hour. Compared with
the long operation time of 9 to 11 hours in Europe,
and longer incision length, this method’s complications
related with anesthesia and surgery were greatly
reduced, and the recovery time after surgery was also

shortened. In particular, 2 hours are the prime time from
the lab until the end of the cell transplantation [20].
Reducing the total injection volume and appropriately increasing the concentration of the cell
suspension is an aspect to be considered. However, the
inner diameter of the needle of the applied syringe is of
utmost importance. Actually excessive cell concentration, or the resistance to flow of the cell suspension
through the needle, can crush and damage the cells.
Therefore, a moderate concentration, a moderate total
volume, and an appropriate number of injection points
are items to be determined in the future studies.
Finally, through the comparison of the results from
multiple centers in this paper, a global consensus can
be considered that association of strong rehabilitation
program is essential for the recovery of the patients’
motor function. Simple cell transplantation, if not
combined with rehabilitation training, cannot trigger
or promote neuromuscular activity [10].

5

Conclusions

The cell implantation into the spinal cord parenchyma has a certain effect on the functional recovery
for chronic complete SCI. Concise surgery that meets
clinical practice may have advantages over seemingly
precise and complex surgical procedures: saving
surgery time, reducing iatrogenic secondary damage,
reducing associated complications, and similar or
better clinical outcomes. Excessive transplant capacity
per unit volume may be an important cause of poor
surgical outcomes. Excessive operative time, excessive
cell population and numerous punctures points may
adversely affect the surgical outcome.
Preliminary recommendations for surgical parameters
include: (1) cell concentration: moderate (10,000–
30,000/μL); (2) total cells: moderate (>1 million/
50–100 μL); (3) incision selection: minimally invasive,
keyhole; (4) transplanted site: junction zone between
normal and abnormal segment can be implanted;
(5) number of transplant sites: 4–8; (6) excellent
transplantation equipment should be suitable for
sterilization and freehand coordination; (7) intraoperative adhesions and cysts are better to be surgically
released or removed; (8) postoperative rehabilitation
should be instituted early with adequate target-oriented
intensive program.
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